Studies have shown that ATP6V1G2 is significantly downregulated in AD, as well as in Parkinson's disease (PD) and Huntington's disease (HD)[39,40], a finding that aligns with our research. This evidence concerns the gene ATP6V1G2 and Alzheimer disease.